Skip to content
healthcare.dev

AUKELSO

NDC 83257-030, Denosumab-kyqq, injection, from Biocon Biologics Inc..

Product NDC
83257-030
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DENOSUMAB120 mg/1.7mL

Pharmacologic classes

RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]

Package NDCNDC-11Package
83257-030-11832570030111 VIAL, SINGLE-USE in 1 CARTON (83257-030-11) / 1.7 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/547cb095-f7f5-f933-75ce-5e6abf2ad5bc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83257-030

Use it

Look up 83257-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.